Nissui Pharmaceutical Stock Forecast for 2023 - 2025 - 2030
Updated on 04/28/2024
Nissui Pharmaceutical Stock Forecast and Price Target
Year-long price target forecasts from prominent analysts have recently been released for Nissui Pharmaceutical, with an average price target of ¥1960.94. This potential gain of 14.41 percent from the previous closing price in November, 2022 is calculated on a high forecast of ¥2196.25 and a low estimate of ¥1745.23.
14.41% Upside
Nissui Pharmaceutical Fair Value Forecast for 2023 - 2025 - 2030
In the last year, Nissui Pharmaceutical's Price has grown from ¥0.00 to ¥0.00 – a 100.00% increase. Next year, analysts are expecting Fair Value to reach ¥1861.93 – an increase of 100.00%. Over the next six years, the forecast is for Fair Value to grow by 100.00%.
Nissui Pharmaceutical Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Nissui Pharmaceutical's Revenue has grown from ¥12.77B to ¥16.66B – a 30.41% increase. In the following year, the 0 analysts surveyed believe that Nissui Pharmaceutical's Revenue will decrease by 16.05%, reaching ¥13.98B. According to professionals, by 2030, Nissui Pharmaceutical's Revenue will have decreased by 14.79%, falling down to ¥14.19B.
.jpg)
Nissui Pharmaceutical Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Nissui Pharmaceutical's Dividend per Share has decreased from ¥30.00 to ¥30.00 – a 0.00% drop! The next year, 0 experts forecast that Nissui Pharmaceutical's Dividend per Share will decrease by 4.45%, reaching ¥28.67. In 2030, professionals predict that Nissui Pharmaceutical's Dividend per Share will decrease by 4.53%, reaching ¥28.64.
Nissui Pharmaceutical EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Nissui Pharmaceutical's EBITDA has grown, rising from ¥1.51B to ¥1.80B – a growth of 19.13%. For the next year, 0 analysts project Nissui Pharmaceutical's EBITDA to drop by 13.36%, reaching ¥1.56B. By 2030, professionals believe that Nissui Pharmaceutical's EBITDA will decrease by 12.82%, reaching ¥1.57B – a concerning trend for the company.
Nissui Pharmaceutical EBIT Forecast for 2023 - 2025 - 2030
Nissui Pharmaceutical's EBIT has grown In the last two years, rising from ¥1.15B to ¥1.56B – a growth of 36.47%. According to 0 prominent analysts, Nissui Pharmaceutical's EBIT will fall by 18.04% in the next year, reaching ¥1.28B. By 2030, professionals believe that Nissui Pharmaceutical's EBIT will decrease by 16.75%, reaching ¥1.30B – a concerning trend for the company.
Nissui Pharmaceutical EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, Nissui Pharmaceutical's EPS has grown from ¥0.00 to ¥0.00 – a 100.00% increase. Next year, analysts are expecting EPS to reach ¥0.00 – an increase of 100.00%. Over the next six years, the forecast is for EPS to grow by 100.00%.
Site Navigation
.jpg)